Drug
EB Dtnb NK
EB Dtnb NK: highest development phase Phase 1/2, developed by Beijing Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Beijing Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| EB-DTNB-NK NCT07502287 | Phase 1/2 | Relapsed Neuroblastoma |
Latest
No recent events.
Follow EB Dtnb NK on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.